News

Magellan Update August 2024

From the Chair Magellan Continues to progress its operational and strategic plans. With a focus on a successful laboratory licensing process for the TGA, publication

Read More »

Magellan Update October 2023

GMP LAB CONSTRUCTION COMPLETED Magellan has completed the construction of the GMP laboratory facility, with the emphasis now on balancing and testing systems. The installation

Read More »

Magellan Update July 2023

MAGELLAN APPOINTS NEW SHARE REGISTRY Magellan is pleased to announce that we have appointed Bio101 – a leading provider of financial, accounting, and company secretarial services

Read More »

Magellan Update April 2023

BUILDERS ON SITE AT NEW LABS. The building process for Magellan’s new laboratories at Braeside has commenced. The development will include two GMP (Good Manufacturing Practice) laboratories.

Read More »

Magellan are pleased to announce the results of our Phase 1/2 allogenic trial. The research findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI), which publishes the evidence-based, international consensus guidelines on osteoarthritis management.  

Australian Health Minister announced a $7 million grant to Magellan Stem Cells – read more here

Should you want further information regarding our results or media release please email info@magellanstemcells.com.au or call 03 9270 8080.

Investment Enquiry

Download the full Investor Presentation